Methyl β-D-glucopyranoside

CAS No. 709-50-2

Methyl β-D-glucopyranoside( —— )

Catalog No. M33611 CAS No. 709-50-2

Methyl β-D-glucopyranoside, utilized in the enzymatic caffeoylation process, is instrumental in synthesizing natural glycophenolics.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG 29 In Stock
1G 41 In Stock

Biological Information

  • Product Name
    Methyl β-D-glucopyranoside
  • Note
    Research use only, not for human use.
  • Brief Description
    Methyl β-D-glucopyranoside, utilized in the enzymatic caffeoylation process, is instrumental in synthesizing natural glycophenolics.
  • Description
    Methyl β-D-glucopyranoside is used to synthesize natural glycophenolics via enzymatic caffeoylation.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    709-50-2
  • Formula Weight
    194.18
  • Molecular Formula
    C7H14O6
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?H2O : 250 mg/mL (1287.47 mM; Ultrasonic)
  • SMILES
    CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Chyba A, et al. Effective enzymatic caffeoylation of natural glucopyranosides. Bioorg Med Chem Lett. 2016 Mar 15;26(6):1567-1570.?
molnova catalog
related products
  • Calmodulin Binding P...

    Calmodulin Binding Peptide 1 is a high affinity (pM) CaM-binding peptide derived from smooth muscle myosin light-chain kinase (MLCK peptide), which strongly inhibits IP3-induced Ca2+ release .

  • (D-Arg2,Sar4)-Dermor...

    (D-Arg2, Sar 4)-Dermorphin (1-4) is a tetrapeptide derivative of the peptide Dermorphin found in amphibian skin. (D-Arg2, Sar 4)-Dermorphin (1-4) has significant analgesic effects by binding to the μ-opioid receptor (MOR) in the body. (D-Arg2, Sar 4)-Dermorphin (1-4) can be used in the development of analgesic drugs.

  • Skp2 inhibitor 1

    Skp2 inhibitor 1 is a Skp2-Cks1 interaction inhibitor (IC50: 2.8μM) with antitumor activity and can be used to study cancer.